Idiopathic aplastic anemia
ICD-10 D61.3 is a billable code used to indicate a diagnosis of idiopathic aplastic anemia.
Idiopathic aplastic anemia is a rare hematological disorder characterized by the failure of the bone marrow to produce adequate amounts of blood cells, leading to pancytopenia (a reduction in red blood cells, white blood cells, and platelets). The term 'idiopathic' indicates that the exact cause of the condition is unknown, although it may be associated with autoimmune disorders, exposure to certain chemicals, drugs, or viral infections. Patients typically present with symptoms such as fatigue, increased susceptibility to infections, and easy bruising or bleeding due to low platelet counts. Diagnosis is confirmed through blood tests showing low blood cell counts and a bone marrow biopsy revealing hypocellular marrow. Treatment options may include immunosuppressive therapy, bone marrow transplantation, or supportive care, depending on the severity of the condition and the patient's overall health. The management of idiopathic aplastic anemia requires a multidisciplinary approach, often involving hematologists and other specialists to monitor and treat complications effectively.
Detailed lab results, bone marrow biopsy reports, and treatment plans.
Diagnosis confirmation, treatment initiation, and monitoring of treatment response.
Ensure that all relevant lab values and clinical symptoms are documented to support the diagnosis.
Comprehensive treatment history, including any chemotherapy or radiation therapy that may affect bone marrow function.
Management of patients with aplastic anemia who have a history of malignancy.
Document any potential secondary causes of aplastic anemia related to cancer treatment.
Used to monitor blood cell levels in patients with aplastic anemia.
Document the reason for the CBC and any relevant findings.
Hematologists should ensure that CBC results are interpreted in the context of the patient's clinical status.
The primary cause of idiopathic aplastic anemia is unknown, but it may be associated with autoimmune processes, environmental factors, or viral infections.
Diagnosis is made through clinical evaluation, blood tests showing low blood cell counts, and a bone marrow biopsy that reveals hypocellular marrow.
Treatment options include immunosuppressive therapy, bone marrow transplantation, and supportive care, depending on the severity of the condition.
